CEO Holmes found guilty of investor scam

Holmes continued to sell after finding out her product was faulty…

Elizabeth Holmes has become the the latest high-profile CEO to be found guilty of an investor scam. The CEO and founder of blood testing start-up Theranos faces sentencing in September after committing two counts of wire fraud, and two counts of conspiracy to commit fraud.

Aged 19, Holmes set out to create a cheaper, less painful, and more convenient way to scan for diseases and health problems. She claimed the solution was to take a few drops of blood from the finger (instead of inserting a needle in a vein).

A revolutionary idea, right? And one that would undoubtedly appeal to a myriad of individuals. These include some of the wealthiest people on the planet looking to invest in something fresh, exciting, and potentially legendary.

Like most start-ups that amass a lot of funds, the key is not simply to hook people in. How the scheme is presented to investors is just as important. But Holmes’ ‘revolutionary’ technology simply never worked.

Determined to con

During the trial, prosecutors sought to prove that Holmes was dead set on the company’s success. She remained determined, even after discovering the product she was selling – a machine called the Edison – was a total sham.

Thereanos’s blood-testing equipment was so flawed, the company allegedly used devices made by competitors to conduct laboratory tests.

Be aware of investor scams

People usually get reeled into new, shiny-looking investment scams because of the way they’re sold. But often they become bitterly disappointed when things don’t live up to their glistening expectations. Many times in these circumstances you may hear the words “But they seemed so legitimate” uttered.

If your company’s in trouble and you keep lying, you may lose investors’ trust, or in this case, face serious jail time. How could this have been avoided? Well, it is worth mentioning that a high percentage of investors are savvy, intelligent people who are not easily duped.

Besides, it’s not like each investor could turn up to the Theranos lab to see if the technology was actually what it claimed to be. For starters, most people have no idea of the science behind Edison to make an informed decision.

As is the case most of the time, investors are not necessarily experts in what they are investing in. There’s simply no need. But there is an element of blind faith. We touched on due diligence recently, and we’ll be posting another article going deeper in due course. So stay tuned…

Posted in

Commercial Debt Collection: Challenges and Best Practices

09/05/2024

Commercial debt collection is the process through which outstanding debts owed by commercial entities are recovered, typically stemming from goods delivered or services rendered on…

Read More
GFSC

Gibraltar Financial Services Commission: A Lesson in Financial Regulation

27/03/2024

The recent collapse of High Street Group and its security trustee, Castle Trust Management and Services, prompts a closer examination of regulatory practices. Along with…

Read More
de trafford

De Trafford Third Party Recovery: An Update

29/02/2024

The recent financial collapse of multiple DeTrafford property development companies hassignificantly impacted purchasers. As they navigate the consequences, a glimmer of hope arises asthe wheels…

Read More
Northumberland Living

Northumberland Living Developments: Allegations and Challenges

22/02/2024

Northumberland Living, In West Chevington Farm, Druridge Bay, is a development poised for completion. Only to be stalled by an apparent unforeseen historical conveyancing issue.…

Read More